ArticleCurrent oncology (Toronto, Ont.)2016

Real-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of age.

S Lupichuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.